A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery
Clinical trial NCT03013127 · TERMINATED
Trial details
- NCT number
- NCT03013127
- Sponsor
- Oslo University Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-30
- Primary completion
- 2018-11-26
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.